Antibiotics enhance binding of lipid A-specific murine monoclonal antibody E5 to Gram-negative bacteria

This publication has 11 references indexed in Scilit:

• Efficacy of Anti-Endotoxin Monoclonal Antibody E5 Alone or in Combination with Ciprofloxacin in Neutropenic Rats with Pseudomonas Sepsis
  The Journal of Infectious Diseases, 1993
• A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group
  Published by American Medical Association (AMA) ,1991
• Role of Antibodies and Antibiotics in Aerobic Gram-Negative Septicemia: Possible Synergism Between Antimicrobial Treatment and Immunotherapy
  Clinical Infectious Diseases, 1991
• Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock
  European Journal of Clinical Microbiology & Infectious Diseases, 1990
• Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface
  Antimicrobial Agents and Chemotherapy, 1990
• The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences
  Journal of Antimicrobial Chemotherapy, 1989
• Protective Antibody to Endotoxin Core: The Emperor's New Clothes?
  The Journal of Infectious Diseases, 1988
• Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria
  European Journal of Clinical Microbiology & Infectious Diseases, 1986
• Complement activating and opsonic capacity of monoclonal antibodies raised againstEscherichia coli O111 and its rough mutant J5
  European Journal of Clinical Microbiology & Infectious Diseases, 1986
• Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum
  Journal of Immunological Methods, 1983